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Abstract
we aimed to evaluate the subcutaneous tissue reaction
to a newly-developed MgO Sealer for root canals. we
injected the experimental material and three existing
control materials into the dorsal area of 43 male ddy
mice. One week and 12 weeks after embedding, the
tissue surrounding the embedding sites was removed
and  histopathological  examination  was  performed.
The results demonstrate that the basic histopathologi-
cal reaction is the formation of fibrous capsules con-
sisting of granulation tissue around the experimental
and control embedded materials. Based on our results,
we believe that the newly-developed MgO Sealer is as
safe as the existing control materials and can be con-
sidered for dental use as a root canal sealer.
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INTRODuCTION
There are numerous materials used in the dental root
canal, icluding medications, root canal filling materials
and sealers. Endodontic sealers are needed to fill un-
avoidable spaces between the solid filling materials and
the root canal walls, and should be both biologically
acceptable and able to bond to dentin.
we have developed a new magnesium oxide (MgO)
sealer,  usable  as  a  root  canal  sealer  for  endodontic
treatment. Because the material is used in vivo, it is
necessary to evaluate the tissue reaction according to
ISO standard 10993-6 [1, 2]. In the present investiga-
tion, we compared the local effects after implantation
of  the  above-mentioned  newly-developed  material
with those of some existing products.
MATERIAlS AND METHODS
MATERIAlS
The materials to be examined include the experimental
MgO Sealer (MS: Neo Dental Chemical Products, Co,
ltd, Tokyo, Japan) and the control, Finapec APC (FP:
produced  by  Kyocera,  Kyoto,  Japan),  Sealapex  (SP:
produced by Kerr Corp, Orange, CA, uSA) and AH
Plus  (AH:  produced  by  Dentsply  De  Trey  gmbh,
Konstanz, germany). The materials were formed into
discoid 6mm in the diameter, and the materials were
prepared  in  the  following  thickness:  NM,  0.86mm; 
FP, 0.75mm; SP, 0.80mm; and AH, 0.77mm. The fun-
damental  data  of  examined  materials  is  shown  in
Table 1.
ANIMAlS
A  total  of  43  male  9-week-old  ddy  mice  weighing
about 35g (30-40g) each were purchased from Japan
SlC Inc. (Hamamatsu, Japan). The animals were kept
in plastic cages with a floor mat (Paper Clean: Peparlet
Co., ltd., Shizuoka, Japan) in an air-conditioned room
with  water  and  solid  diet  (Picolab  Rodent  Diet  20:
Japan SlC Inc., Hamamatsu, Japan) during the experi-
mental periods, which lasted 12 weeks. The Matsumo-
to Dental university Committee for Animal Experi-
mentation approved the study.
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Table 1. Main Components of Experimental and Control Materials.
Materials Main Components
Experimental MgO Sealer zinc oxide, magnesium oxide, bismuth oxide, methyl salicylate, guaiacol
Control Finapec APC hydroxyapatite, magnesium oxide, zinc oxide, bismuth subcarbonate, guaiacol, eucalyptol
Sealapex Isobutyl salicylate resin, silicon dioxide, bismuth trioxide, titanium dioxide pigment, 
N-ethyl toluene sulfoamide resin, zinc oxide, calcium oxide
AH Plus Diepoxide, calcium tungstate, zirconium oxide, aerosil, pigment, 1-adamantane amine, 
NN’-dibenzyl-5-oxa-nonandiamin-1,9, TCD-diamine, silicone oil
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Prior  to  the  examination,  inhalation  anesthesia  was
used with an isoflurane (Isoflu: Dainippon Sumitomo
Pharma Co., Osaka, Japan) and gas-air mixture (4.0%
concentration).  Immediately  after  the  dorsal  area  of
the mice was disinfected with 70% ethanol, the inci-
sion was made and the materials were injected subcu-
taneously into the connective tissues. The skin surface
at the incision site was sutured using suture string. The
site was marked every 2 weeks until the final examina-
tion period at 12 weeks (Table 2).
At 1 week and 12 weeks after injection, 4-6 mice
from  each  group  were  anesthetized  with  isoflurane
and gas-air mixture, and the tissue surrounding the in-
jection sites were excised. The excised tissues were im-
mediately fixed in 4% paraformaldehyde/0.5M phos-
phate  buffered  solution,  embedded  in  paraffin,  and
sections prepared.
The tissue sections were stained with hematoxylin
and eosin and examined by light microscopy for histo  -
pathological  changes.  we  followed  the  International
Organization for Standardization (ISO) guidelines for
evaluating the local effects of injection materials.
RESulTS
ExPERIMENTAl MgO SEAlER [MS]
Histopathologically,  according  to  observation  of  the
1-week specimens, the embedded MS was slightly bro-
ken, and a dark brown or black granulated structure
was  observed,  sometimes  with  eosin-stained  amor-
phous  substances.  Some  substances  were  peeled  off
from the slide glasses. At the periphery of these mate-
rials,  a  layer  of  necrotic  tissue  was  formed,  which
showed a comparatively eosin-stained uniform struc-
ture (Fig. 1-a). under the necrotic tissue, fibroblasts
proliferated and formed granulation tissue (Fig. 1-b).
In the granulation tissue, a small amount of bleeding
was evident.
In  the  12-week  specimens,  around  the  peripheral
necrotic tissue of the MS, macrophages were greatly
evident in the proliferating granulation tissues. The cy-
toplasms  of  macrophages  contained  many  granular
structures  (Fig.1-c),  suggesting  phagocytosis  of  the
MS (Fig. 1-d).
CONTROl MATERIAlS
Material #1: Finapec APC [FP]
In  1-week  specimens,  the  embedded  material  FP,
which was observed as eosin-stained fine granular sub-
stances (Fig. 2-a), was encapsulated by comparatively
thick  granulation  tissues  with  rich  inflammatory  cell
infiltration but without neutrophilic leucocytes (Fig. 2-
b). In the granulation tissues, fibroblast proliferation
was evident, having some enlarged capillaries showing
hyperemia.
In 12-week specimens, inflammatory cell infiltration
almost disappeared in the proliferated granulation tis-
sue forming around the embedded FP; however, there
were  some  inflammatory  cell  infiltration  and  hyper-
emia  in  the  granulation  tissues  (Fig.  2-c).  Fibrosis
gradually occurred in the granulation tissues, but there
were  some  inflammatory  cell  infiltration  and  hyper-
emia in localized regions (Fig. 2-d).
Material #2: Sealapex [SP]
In 1-week specimens, the embedded material SP was
observed  as  eosin-stained  and/or  dark-brown/black
fine granular combined structures (Fig. 3-a). The sur-
rounding tissue consisted of lamellar fibrous granula-
tion tissues with slightly necrotic changes. There were
almost no infiltrations in the fibrous tissues (Fig. 3-b).
upon removal of the 12-week specimens, the em-
bedded SP was not observed as a block structure. Ac-
cording to naked eye observation, some dark brown
pigmentation was noted on the proliferated granula-
tion  tissue  masses.  As  observed  histopathologically,
small granulation tissue masses were evident, and the
phagocytosed embedded materials were confirmed as
fine granular brown pigments within the macrophages
in  the  granulation  tissues  (Fig.  3-c).  Furthermore,
some  hematoxylin-deeply  stained  calcified  structures
were evident (Fig. 3-d).
Material #3: AH Plus [AH]
In 1-week specimens, there was observed granulation
tissue  around  the  embedded  material  AH  (Fig.  4-a).
The material contact surface of the granulation tissues
was composed of quite thin fibrous capsules, in which
comparative strong inflammatory cell infiltrations ap-
peared, mainly infiltrations of lymphocytes and plas-
ma cells. In localized regions, there were some prolif-
erated capillaries and histopathological features of hy-
peremia (Fig. 4-b).
In 12-week specimens, inflammatory cell infiltration
had almost disappeared in the fibrous tissues which
encapsulated the embedded AH (Fig. 4-c). The materi-
al-contact  surface  of  the  fibrous  capsule  tissue  was
quite thin at first, and had almost no inflammatory cell
infiltration (Fig. 4-d). 
DISCuSSION
Successful endodontic treatment depends on the open-
ing of the pulp chamber, cleaning, irrigation or appli-
cation of medication, and obturation of the root canal
system. After that, the irrigated root canal is then filled
with paste material or is obturated with solid materials
such as gutta-percha points using a sealer [3, 4]. vari-
ous sealers have been produced, each containing differ-
ent components. One such product, a mixture of calci-
um hydroxide, zinc oxide, guaiacol and magnesium ox-
ide, is used as medication root canal filling material and
sealer [5, 6].  Because sealer contacting the periodontal
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Table 2. Experimental Periods and Number of Animals.
Periods 1 week 12 weeks Total
Experimental MgO Sealer 54 9
Control Finapec APC 66 12
Sealapex 65 11
AH Plus 56 11
Total 43
2) Nakano-Kawakami###_Umbruchvorlage  14.11.11  11:24  Seite 527EuROPEAN JOuRNAl OF MEDICAl RESEARCH 528 December 2, 2011
Fig. 1. Experimental (MS) specimen. a: 1-week specimen, x 50; b: 1-week specimen, x 100; c: 12-week specimen, x 50; d:
12-week specimen, x 100.
Fig. 2. Control #1 (FP) specimen. a: 1-week specimen, x 50; b: 1-week specimen, x 100; c: 12-week specimen, x 50; d: 12-
week specimen, x 100.
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Fig. 3. Control #2 (SP) specimen. a: 1-week specimen, x 50; b: 1-week specimen, x 100; c: arrow: granular fine pigments,
12-week specimen, x 50; d: arrows: calcified materials, 12-week specimen, x 100.
Fig. 4. Control #3 (AH) specimen. a: 1-week specimen, x 50; b: 1-week specimen, x 100; c: 12-week specimen, x 50; d: 12-
week specimen, x 100.
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tissues through the apical foramen may generate differ-
ent reactions in the tissues, it is important to select a
suitable  material  for  endodontic  treatment  for  long-
term success. For instance, Khashba et al. (2011) exam-
ined a newly-developed calcium phosphate-based seal-
ers by histopathological comparison with the commer-
cially available calcium hydroxide-based sealer Acroseal
[6].  Other  reports  have  described  tissue  reactions  to
various  materials  as  well  as  biocompatibilities,  using
commercially-available  sealers  such  as  Acroseal,
Sealapex,  CRCS,  AH-26,  Tubli  Seal,  RoekoSeal,  AH-
Plus, Canals, and Finapex APC [7, 8, 9, 10, 11, 12, 13].
For  our  new  magnesium  oxide  containing  paste,
MgO Sealer, MS, we selected magnesium oxide as a
component based on the findings of Maeda [14], who
described the tissue reaction of magnesium oxide as
follows. Magnesium oxide caused few symptoms and
exerts a very slight irritating influence to the tissues. It
is, therefore, considered very useful as a basic material
in endodontic therapy. 
Our  present  examination  of  1-week  specimens
showed  slightly  broken  MS  as  dark  brown  or  black
granulated,and at the periphery of MS, a layer of necro  -
tic tissue was formed. The phenomenon was consid-
ered to occur due to the magnesium oxide component;
however, beneath the necrotic tissue, there were nu-
merous fibroblastic tissues. This seems to indicate that
the irritation caused MS is comparatively less than that
of calcium hydroxide sealers [5]. In SP specimens at
12-weeks, the embedded materials were broken in the
proliferated granulation tissues and the macrophage’s
phagocytosis figures and calcified materials were evi-
dent in the tissues, features which have also been noted
by  Hauman  and  love  [17].  The  calcification  was
thought to be caused by the calcium oxide component.
Furthermore, there was little bleeding in the granula-
tion tissue formation in 1-week specimens, which also
indicates the improved biocompatibility. Regarding the
12-week  specimens,  the  features  of  macrophages
showed aggressive repair. This means the component
does  not  cause  any  damage  even  though  it  is  not
phagocytosed by the macrophages. granulation tissue
rich in cells proliferates around the embedded site.
In  conclusion,  we  examined  local  effects  through
the subcutaneous tissue reaction to a newly-developed
MgO Sealer using three existing control materials, and
based on our results, we believe that the new devel-
oped material is as safe as three control materials and
is adequate for use within root canals.
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